Published in Urology on August 01, 2005
Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment | NCT03229889
Early ureteral catheter removal after ureteroscopic lithotripsy using ureteral access sheath. Urolithiasis (2012) 1.25
CUA Guideline: Management of ureteral calculi. Can Urol Assoc J (2015) 1.14
The use of a ureteral access sheath does not improve stone-free rate after ureteroscopy for upper urinary tract stones. World J Urol (2013) 0.89
Treatment of renal stones with flexible ureteroscopy in preschool age children. Urolithiasis (2013) 0.88
Differences in renal stone treatment and outcomes for patients treated either with or without the support of a ureteral access sheath: The Clinical Research Office of the Endourological Society Ureteroscopy Global Study. World J Urol (2015) 0.84
Endoscopic management of upper tract transitional cell carcinoma. Indian J Urol (2010) 0.82
First clinical evaluation of a new innovative ureteral access sheath (Re-Trace™): a European study. World J Urol (2013) 0.80
Use of ureteral access sheaths in ureteroscopy. Nat Rev Urol (2015) 0.80
Extracorporeal shockwave lithotripsy vs. percutaneous nephrolithotomy vs. flexible ureterorenoscopy for lower-pole stones. Arab J Urol (2012) 0.79
Percutaneous nephrolithotomy for the treatment of lower pole renal calculi. Can Urol Assoc J (2008) 0.79
Stone volume is best predictor of operative time required in retrograde intrarenal surgery for renal calculi: implications for surgical planning and quality improvement. Urolithiasis (2016) 0.79
Retrograde intrarenal surgery for lower pole renal calculi smaller than one centimeter. Indian J Urol (2008) 0.77
Controversies in ureteroscopy: Wire, basket, and sheath. Indian J Urol (2013) 0.77
Endourologic management of upper tract transitional cell carcinoma following cystectomy and urinary diversion. Adv Urol (2008) 0.77
Intrarenal Surgery vs Percutaneous Nephrolithotomy in the Management of Lower Pole Stones Greater than 2 cm. Int Braz J Urol (2015) 0.76
Intrarenal pressure and irrigation flow with commonly used ureteric access sheaths and instruments. Cent European J Urol (2015) 0.75
Optimizing Stone-free Rates With Ureteroscopy. Rev Urol (2015) 0.75
Is a ureteral stent required after use of ureteral access sheath in presented patients who undergo flexible ureteroscopy? Cent European J Urol (2016) 0.75
Fluoroscopy free flexible ureteroscopy with holmium: Yttrium-aluminium-garnet laser lithotripsy for removal of renal calculi. Arab J Urol (2016) 0.75
The Single Wire Ureteral Access Sheath, Both Safe and Economical. Adv Urol (2016) 0.75
Managing caliceal stones. Indian J Urol (2014) 0.75
Factors affecting complication rates of retrograde flexible ureterorenoscopy: analysis of 1571 procedures-a single-center experience. World J Urol (2016) 0.75
Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy. Eur Urol (2008) 4.75
Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol (2005) 4.69
Comparative effectiveness of shock wave lithotripsy and ureteroscopy for treating patients with kidney stones. JAMA Surg (2014) 2.89
Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study. J Urol (2013) 2.76
Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening. J Urol (2007) 2.42
Prospective randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol (2008) 2.40
Prospective, randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol (2005) 2.31
Changing gender prevalence of stone disease. J Urol (2007) 2.25
A novel drug eluting ureteral stent: a prospective, randomized, multicenter clinical trial to evaluate the safety and effectiveness of a ketorolac loaded ureteral stent. J Urol (2010) 2.21
Clinical outcomes after ureteroscopic lithotripsy in patients who initially presented with urosepsis: matched pair comparison with elective ureteroscopy. J Endourol (2014) 2.17
A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature. J Urol (2007) 2.16
Public survey and survival data do not support recommendations to discontinue prostate-specific antigen screening in men at age 75. Urology (2009) 2.09
Beyond prone position in percutaneous nephrolithotomy: a comprehensive review. Eur Urol (2008) 2.05
Tumor percent involvement predicts prostate specific antigen recurrence after radical prostatectomy only in men with smaller prostate. J Urol (2010) 2.05
Percutaneous management of calculi within horseshoe kidneys. J Urol (2003) 2.04
Urinary diversion in patients with spinal cord injury in the United States. Urology (2012) 2.03
Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev (2008) 1.99
Clinical effectiveness protocols for imaging in the management of ureteral calculous disease: AUA technology assessment. J Urol (2012) 1.94
The role of stress waves and cavitation in stone comminution in shock wave lithotripsy. Ultrasound Med Biol (2002) 1.92
Renal stone assessment with dual-energy multidetector CT and advanced postprocessing techniques: improved characterization of renal stone composition--pilot study. Radiology (2009) 1.90
Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras. J Urol (2009) 1.85
A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg (2010) 1.83
Pain after percutaneous nephrolithotomy: impact of nephrostomy tube size. J Endourol (2003) 1.83
Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol (2008) 1.82
Defining potency: a comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite. Cancer (2008) 1.71
Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol (2004) 1.70
Geographic variations in the use of medical and surgical therapies for benign prostatic hyperplasia. J Urol (2006) 1.67
Metabolic abnormalities associated with renal calculi in patients with horseshoe kidneys. J Endourol (2004) 1.65
Determining the incidence of horseshoe kidney from radiographic data at a single institution. J Urol (2003) 1.64
Ureteral access sheath provides protection against elevated renal pressures during routine flexible ureteroscopic stone manipulation. J Endourol (2004) 1.63
Positive surgical margins after robotic assisted radical prostatectomy: a multi-institutional study. J Urol (2011) 1.62
Reduced radiation exposure with the use of an air retrograde pyelogram during fluoroscopic access for percutaneous nephrolithotomy. J Endourol (2011) 1.61
Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death. Cancer (2010) 1.59
Factors predicting prostatic biopsy Gleason sum under grading. J Urol (2009) 1.59
Treatment efficacy and outcomes using a third generation shockwave lithotripter. BJU Int (2013) 1.57
The surgical management of stones in patients with urinary diversions. Curr Opin Urol (2004) 1.54
Radiation exposure in the acute and short-term management of urolithiasis at 2 academic centers. J Urol (2008) 1.53
Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: recommendations of the society of urologic robotic surgeons. J Urol (2009) 1.53
Complications of laparoscopic and percutaneous renal cryoablation in a single tertiary referral center. Eur Urol (2010) 1.53
Determination of patient radiation dose during ureteroscopic treatment of urolithiasis using a validated model. J Urol (2012) 1.51
Biochemical profile of stone-forming patients with diabetes mellitus. Urology (2003) 1.51
Comparison of three different tools for prediction of seminal vesicle invasion at radical prostatectomy. Eur Urol (2012) 1.50
Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature. J Urol (2008) 1.48
Pretreatment expectations of patients undergoing robotic assisted laparoscopic or open retropubic radical prostatectomy. J Urol (2012) 1.47
Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis. Kidney Int (2003) 1.46
Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk. J Urol (2010) 1.45
Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma. J Endourol (2011) 1.45
Predicting occult multifocality of renal cell carcinoma. Eur Urol (2010) 1.45
The effect of dietary sodium and fructose intake on urine and serum parameters of stone formation in a pediatric mouse model: a pilot study. J Urol (2013) 1.44
Defining hypercalciuria in nephrolithiasis. Kidney Int (2011) 1.44
Effect of age and pathologic Gleason score on PSA recurrence: analysis of 2911 patients undergoing radical prostatectomy. Urology (2009) 1.44
Innovations in shock wave lithotripsy technology: updates in experimental studies. J Urol (2004) 1.36
Surgical simulation: a urological perspective. J Urol (2008) 1.34
Shock wave lithotripsy or ureteroscopy for the management of proximal ureteral calculi: an old discussion revisited. J Urol (2007) 1.32
Cost comparison among robotic, laparoscopic, and open hysterectomy for endometrial cancer. Obstet Gynecol (2010) 1.31
Simultaneous combined use of flexible ureteroscopy and percutaneous nephrolithotomy to reduce the number of access tracts in the management of complex renal calculi. BJU Int (2005) 1.30
The effect of treatment strategy on stone comminution efficiency in shock wave lithotripsy. J Urol (2004) 1.29
Reporting of harm in randomized controlled trials published in the urological literature. J Urol (2010) 1.25
Subcutaneous bupivacaine infiltration and postoperative pain perception after percutaneous nephrolithotomy. J Urol (2007) 1.24
How to use a systematic literature review and meta-analysis. J Urol (2008) 1.23
Local cost structures and the economics of robot assisted radical prostatectomy. J Urol (2005) 1.23
Internet based multi-institutional clinical research: a convenient and secure option. J Urol (2004) 1.23
Management of nephropleural fistula after supracostal percutaneous nephrolithotomy. Urology (2004) 1.22
Induction of tolerance to heart transplants by simultaneous cotransplantation of donor kidneys may depend on a radiation-sensitive renal-cell population. Transplantation (2003) 1.18
Practice variation in the surgical management of urinary lithiasis. J Urol (2011) 1.16
Evidence based clinical practice: a primer for urologists. J Urol (2007) 1.13
Routine ureteral stenting is not necessary after ureteroscopy and ureteropyeloscopy: a randomized trial. J Endourol (2002) 1.13
Laser Doppler flowmetric determination of ureteral blood flow after ureteral access sheath placement. J Endourol (2002) 1.12
Hand assisted laparoscopic training for postgraduate urologists: the role of mentoring. J Urol (2004) 1.11
Disposable devices for RIRS: where do we stand in 2013? What do we need in the future? World J Urol (2014) 1.09
Holmium laser for stone management. World J Urol (2007) 1.09
Ureteroscopic management of renal calculi in anomalous kidneys. Urology (2005) 1.08
Progressive increase of lithotripter output produces better in-vivo stone comminution. J Endourol (2006) 1.08
Safety and efficacy of holmium: YAG laser lithotripsy in patients with bleeding diatheses. J Urol (2002) 1.07
Effect of medical management on recurrent stone formation following percutaneous nephrolithotomy. J Urol (2007) 1.06
Assessing the impact of ureteral stent design on patient comfort. J Urol (2009) 1.06
High definition laparoscopy: objective assessment of performance characteristics and comparison with standard laparoscopy. J Endourol (2009) 1.06